MALAT1 and endometrial cancer: Subsequently, relative expression levels of MYST4 and MALAT1 in eight gynecological cancer cell lines, including six OC lines and two endometrial cancer cell lines, were evaluated by a real-time PCR analysis normalized to HTB75 expression.